MSK Monmouth — Middletown, New Jersey

MSK Monmouth is a clinical research site located in Middletown, New Jersey, United States 07748.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Monmouth has participated in 15 clinical trials with 11 currently active.

Therapeutic areas: Multiple Myeloma, Advanced Malignancies, NSCLC.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Monmouth?

MSK Monmouth has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Monmouth conducted?

MSK Monmouth has 15 clinical trials on record, with 11 currently active. Their work covers Multiple Myeloma, Advanced Malignancies, NSCLC.

Is MSK Monmouth accredited by Crixeo Health?

Yes — MSK Monmouth holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MSK Monmouth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.